SYROS PHARMACEUTICALS INC (SYRS) Stock Income Statement
USA - NASDAQ:SYRS - US87184Q2066 - Common Stock
0.1172 USD
-0.01 (-8.44%)
0.1072 USD
-0.01 (-8.53%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 386.00K | 9.94M | 14.88M | 23.49M | 15.09M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 111.91M | 136.44M | 141.24M | 122.91M | 97.39M | |||
| Research and Development | 88.64M | 108.15M | 111.94M | 99.87M | 76.07M | |||
| Selling, General, and Administrative Expenses | 23.27M | 28.28M | 29.30M | 23.04M | 21.33M | |||
| Operating Income | -111.52M | -126.50M | -126.36M | -99.42M | -82.30M | |||
| Interest Income/Expense | -623.00K | 1.69M | -2.00M | -3.82M | -1.37M | |||
| Other Income/Expense | 14.47M | -37.27M | 43.22M | 16.68M | -380.00K | |||
| Non Recurring Items | null | -2.49M | -9.51M | null | null | |||
| Income Before Taxes | -97.81M | -164.57M | -94.65M | -86.56M | -84.04M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -97.81M | -164.57M | -94.65M | -86.56M | -84.04M | |||
| EBITDA | -110.18M | -124.25M | -123.39M | -96.40M | -79.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.0301 | -5.81 | -7.49 | -13.84 | -18.22 | |||
| Non GAAP EPS | -3.0300000000000002 | -5.76 | -12.780000000000001 | -13.8 | -18.2 | |||
| Statistics | ||||||||
| Profit Margin | -25340.67% | -1656.34% | -636.09% | -368.50% | -556.93% | |||
| Operating Profit Margin | -28892.23% | -1273.14% | -849.19% | -423.24% | -545.39% | |||
All data in USD